Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The update shows a new revision label (v3.3.4) replacing the previous v3.3.3, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:46:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section with California and Florida sites. Removed separate California and Florida location blocks and the HHS Vulnerability Disclosure, and updated to revision v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T13:31:33.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Minor site revision tag updated from v3.3.1 to v3.3.2, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:25:27.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The revision history now shows Revision: v3.3.1, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:38:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The funding-status banner about a lapse in government funding and potential processing delays has been removed. This banner previously informed users about operating status and data currency.
    Difference
    0.3%
    Check dated 2025-11-17T06:47:37.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page (NCT02658968); the content appears unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:16:15.000Z thumbnail image

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.